|
Avience Biomedicals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
136.03 Cr.
|
P/BV
|
6.19
|
Book Value (Rs.)
|
40.07
|
|
52 Week High/Low (Rs.)
|
415/222
|
FV/ML
|
10/600
|
P/E(X)
|
20.20
|
|
Bookclosure
|
|
EPS (Rs.)
|
12.28
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 |
| | | | |
| | | | |
| INCOME | | | |
| Revenue From Operations [Net] | 52.51 | 45.24 | 23.96 |
| Total Operating Revenues | 52.51 | 45.24 | 23.96 |
| | | | |
| Other Income | 0.29 | 0.73 | 0.41 |
| Total Revenue | 52.80 | 45.97 | 24.37 |
| | | | |
| EXPENSES | | | |
| Cost Of Materials Consumed | 5.62 | 3.30 | 2.16 |
| Purchase Of Stock-In Trade | 26.98 | 24.46 | 18.26 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -3.77 | -0.70 | -4.83 |
| Employee Benefit Expenses | 4.52 | 3.21 | 2.02 |
| Finance Costs | 1.54 | 1.48 | 0.92 |
| Depreciation And Amortisation Expenses | 1.22 | 0.86 | 0.62 |
| Other Expenses | 4.22 | 3.55 | 2.28 |
| Total Expenses | 40.33 | 36.17 | 21.43 |
| | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 12.47 | 9.80 | 2.95 |
| | | | |
| Profit/Loss Before Tax | 12.47 | 9.80 | 2.95 |
| | | | |
| Tax Expenses-Continued Operations | | | |
| Current Tax | 3.71 | 2.51 | 0.75 |
| Deferred Tax | 0.00 | 0.06 | 0.05 |
| Total Tax Expenses | 3.71 | 2.57 | 0.80 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 8.75 | 7.23 | 2.14 |
| | | | |
| Profit/Loss From Continuing Operations | 8.75 | 7.23 | 2.14 |
| | | | |
| Profit/Loss For The Period | 8.75 | 7.23 | 2.14 |
| Consolidated Profit/Loss After MI And Associates | 8.75 | 7.23 | 2.14 |
| | | | |
| OTHER INFORMATION | | | |
| | | | |
| EARNINGS PER SHARE | | | |
| Basic EPS (Rs.) | 21.71 | 19.06 | 6.52 |
| Diluted EPS (Rs.) | 21.71 | 19.06 | 19.06 |
